CLASS II ONGOING Drug recall · Reported 4 Dec 2024 · FDA Enforcement Report

Liceout, Liquid Lice Treatment for Human Use, Contents: mL) per jug recalled

Neogen is recalling Liceout, Liquid Lice Treatment for Human Use, Contents: mL) per jug. The recall was initiated on 8 Oct 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot, expiry: LO09530, exp 11/3/2024; LO13412, exp 12/7/2024; LO10263, exp 1/26/2025; LO11303, exp 5/10/2025; LO12153, exp 8/3/2025; LO12483, exp 9/5/2025; LO13183, exp 11/14/2025; LO106024, exp 2/29/2026; LO108624, exp 3/26/2026; LO110224, exp 4/11/2026
Quantity recalled8,328 jugs

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0074-2025
FDA event ID
95823
Recalling firm
Neogen, Lexington, KY
Classification
Class II
Status
Ongoing
Recall initiated
8 Oct 2024
FDA classified
27 Nov 2024
Reported
4 Dec 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

8 Oct 2024Recall initiated by company
27 Nov 2024Classified by FDA+50 days
4 Dec 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP violations.

Product as listed by the FDA

LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53247-124-02

Where it was distributed

Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.

Questions about this recall

Why was it recalled?

CGMP violations.

Which lots are affected?

Lot, expiry: LO09530, exp 11/3/2024; LO13412, exp 12/7/2024; LO10263, exp 1/26/2025; LO11303, exp 5/10/2025; LO12153, exp 8/3/2025; LO12483, exp 9/5/2025; LO13183, exp 11/14/2025; LO106024, exp 2/29/2026; LO108624, exp 3/26/2026; LO110224, exp 4/11/2026

Where was it sold?

Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 95823

This product is part of a recall event; the main page for the event is Liceout, Liquid Lice Treatment for Human Use, Contents: per sachet recalled.

More recalls from Neogen

All 2